Health Catalyst (HCAT) Revenue (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Revenue data on file, last reported at $70.8 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 10.9% year-over-year to $70.8 million; the trailing twelve-month figure through Mar 2026 stood at $302.5 million (down 2.83% YoY), and the FY2025 full-year result was $311.1 million, up 1.48% from the prior year.
• Revenue for Q1 2026 stood at $70.8 million, down from $74.7 million in the prior quarter.
• Across five years, Revenue topped out at $80.7 million in Q2 2025 and bottomed at $68.1 million in Q1 2022.
• The 5-year median for Revenue is $74.7 million (2025), against an average of $74.2 million.
• The widest annual swing landed in 2022, when Revenue gained 21.92%; it then retreated 10.9% in 2026.
• A 5-year view of Revenue shows it stood at $69.2 million in 2022, then climbed by 8.56% to $75.1 million in 2023, then advanced by 6.02% to $79.6 million in 2024, then dropped by 6.19% to $74.7 million in 2025, then declined by 5.25% to $70.8 million in 2026.
• The last three Revenue figures came in at $70.8 million (Q1 2026), $74.7 million (Q4 2025), and $76.3 million (Q3 2025), per Business Quant data.

Peer Comparison